Detalles de la búsqueda
1.
Prevalence and Natural History of Segmental Colitis Associated With Diverticulosis.
Am J Gastroenterol
; 118(11): 2088-2092, 2023 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37314163
2.
Prognostic performance of the 'DICA' endoscopic classification and the 'CODA' score in predicting clinical outcomes of diverticular disease: an international, multicentre, prospective cohort study.
Gut
; 71(7): 1350-1358, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34702716
3.
Real-Life Effectiveness and Safety of Golimumab and Its Predictors of Response in Patients with Ulcerative Colitis.
Dig Dis Sci
; 65(6): 1767-1776, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31722059
4.
Effectiveness and Safety of Pylera® in Patients Infected by Helicobacter Pylori: A Multicenter, Retrospective, Real Life Study.
Dig Dis
; 36(4): 264-268, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29669354
5.
Ustekinumab safety and effectiveness in patients with ulcerative colitis: results from a large real-life study.
Expert Opin Biol Ther
; 24(1-2): 101-109, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38250818
6.
Diverticular Inflammation and Complication Assessment classification, CODA score and fecal calprotectin in clinical assessment of patients with diverticular disease: A decision curve analysis.
United European Gastroenterol J
; 11(7): 642-653, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37550901
7.
Comparison of Performances of Adalimumab Biosimilars SB5, ABP501, GP2017, and MSB11022 in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study.
Inflamm Bowel Dis
; 29(3): 376-383, 2023 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35579320
8.
Real-world efficacy and safety of vedolizumab in managing ulcerative colitis versus Crohn's disease: results from an Italian multicenter study.
Expert Opin Biol Ther
; 23(3): 293-304, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36843568
9.
Use of tofacitinib as first or second-line therapy is associated with better outcomes in patients with ulcerative colitis: data from a real-world study.
Expert Opin Pharmacother
; 24(14): 1649-1656, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37358928
10.
Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy.
Expert Opin Biol Ther
; 22(2): 313-320, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34904510
11.
Replacement of Adalimumab Originator to Adalimumab Biosimilar for a Non-Medical Reason in Patients with Inflammatory Bowel Disease: A Real-life Comparison of Adalimumab Biosimilars Currently Available in Italy.
J Gastrointestin Liver Dis
; 31(4): 411-416, 2022 12 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-36535057
12.
Long-term, Real-life, Observational Study in Treating Outpatient Ulcerative Colitis with Golimumab.
J Gastrointestin Liver Dis
; 30(4): 456-461, 2021 12 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-34812437
13.
Long-term real-life efficacy and safety of infliximab and adalimumab in the treatment of inflammatory bowel diseases outpatients.
Eur J Gastroenterol Hepatol
; 33(5): 670-679, 2021 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33741797
14.
Effectiveness and Safety of A Nutraceutical Formulation for the Treatment of Functional Dyspepsia in Primary Care.
Rev Recent Clin Trials
; 16(3): 329-334, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34126909
15.
Infliximab biosimilar CT-P13 is effective and safe in treating inflammatory bowel diseases: a real-life multicenter, observational study in Italian primary inflammatory bowel disease centers.
Ann Gastroenterol
; 32(4): 392-399, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31263362
16.
Vedolizumab is effective and safe in real-life treatment of inflammatory bowel diseases outpatients: A multicenter, observational study in primary inflammatory bowel disease centers.
Eur J Intern Med
; 66: 85-91, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31208827
17.
Effectiveness and safety of adalimumab to treat outpatient ulcerative colitis: A real-life multicenter, observational study in primary inflammatory bowel disease centers.
Medicine (Baltimore)
; 97(34): e11897, 2018 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-30142791
18.
Effectiveness and safety of infliximab biosimilar CT-P13 in treating ulcerative colitis: a reallife experience in IBD primary centers.
Minerva Gastroenterol Dietol
; 63(4): 313-318, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28293938
19.
Effectiveness and Safety of Golimumab in Treating Outpatient Ulcerative Colitis: A Real-Life Prospective, Multicentre, Observational Study in Primary Inflammatory Bowel Diseases Centers.
J Gastrointestin Liver Dis
; 26(3): 239-244, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28922435
20.
Effectiveness of golimumab in inducing remission and clinical response in outpatient ulcerative colitis.
Clin Res Hepatol Gastroenterol
; 40(5): e61-e63, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27297910
Resultados
1 -
20
de 20
1
Próxima >
>>